PL1916913T3 - Preparat białkowy do leczenia uwarunkowanego fizjologicznie klinicznie nie zwracającego uwagi, zwiększonego zapotrzebowania na białko - Google Patents

Preparat białkowy do leczenia uwarunkowanego fizjologicznie klinicznie nie zwracającego uwagi, zwiększonego zapotrzebowania na białko

Info

Publication number
PL1916913T3
PL1916913T3 PL06778335T PL06778335T PL1916913T3 PL 1916913 T3 PL1916913 T3 PL 1916913T3 PL 06778335 T PL06778335 T PL 06778335T PL 06778335 T PL06778335 T PL 06778335T PL 1916913 T3 PL1916913 T3 PL 1916913T3
Authority
PL
Poland
Prior art keywords
protein
treating
increased need
clinically normal
protein composition
Prior art date
Application number
PL06778335T
Other languages
English (en)
Inventor
Armand Herberger
Original Assignee
Armand Herberger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armand Herberger filed Critical Armand Herberger
Publication of PL1916913T3 publication Critical patent/PL1916913T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/185Vegetable proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL06778335T 2005-08-23 2006-08-23 Preparat białkowy do leczenia uwarunkowanego fizjologicznie klinicznie nie zwracającego uwagi, zwiększonego zapotrzebowania na białko PL1916913T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05018276 2005-08-23
EP06778335A EP1916913B1 (de) 2005-08-23 2006-08-23 Proteinzusammensetzung zur behandlung eines physiologisch bedingten, klinisch unauffälligen proteinmehrbedarfs
PCT/EP2006/065611 WO2007023172A2 (de) 2005-08-23 2006-08-23 Proteinzusammensetzung zur behandlung eines physiologisch bedingten, klinisch unauffälligen proteinmehrbedarfs

Publications (1)

Publication Number Publication Date
PL1916913T3 true PL1916913T3 (pl) 2011-04-29

Family

ID=35276227

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06778335T PL1916913T3 (pl) 2005-08-23 2006-08-23 Preparat białkowy do leczenia uwarunkowanego fizjologicznie klinicznie nie zwracającego uwagi, zwiększonego zapotrzebowania na białko

Country Status (5)

Country Link
EP (1) EP1916913B1 (pl)
AT (1) ATE487390T1 (pl)
DE (1) DE502006008291D1 (pl)
PL (1) PL1916913T3 (pl)
WO (1) WO2007023172A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011078654A1 (en) 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
RU2634407C2 (ru) 2012-03-26 2017-10-26 Эксселла Хелт Инк. Фрагменты пищевых белков и способы их применения
EP2831100A4 (en) 2012-03-26 2016-02-10 Pronutria Inc NUTRIENT PROTEINS AND METHOD
US9700071B2 (en) 2012-03-26 2017-07-11 Axcella Health Inc. Nutritive fragments, proteins and methods
EP2831098A4 (en) 2012-03-26 2016-12-07 Axcella Health Inc LOADED NUTRIENT PROTEINS AND METHODS
RU2016110800A (ru) 2013-09-25 2017-10-30 Пронутриа Биосайенсис, Инк. Составы и композиции для поддержания и увеличения мышечной массы, силы и результативности, и способы их производства и использования

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
US5242697A (en) * 1990-10-26 1993-09-07 Maurizio Luca Method of preparing nutrified food products
GB0110288D0 (en) * 2001-04-26 2001-06-20 Novartis Nutrition Ag Composition and treatment method
EP1479300B1 (en) * 2002-02-22 2009-10-21 Ajinomoto Co., Inc. Amino acid powder and process for producing the same
US7037522B2 (en) * 2002-09-27 2006-05-02 Western Holdings, L.L.C. Nocturnal muscle enhancing composition and method
JP4970694B2 (ja) * 2002-12-02 2012-07-11 株式会社明治 持続性筋肉疲労改善剤
JP5074661B2 (ja) * 2002-12-26 2012-11-14 味の素株式会社 肝癌発生・進展抑制剤

Also Published As

Publication number Publication date
EP1916913B1 (de) 2010-11-10
WO2007023172A3 (de) 2007-09-07
EP1916913A2 (de) 2008-05-07
WO2007023172A2 (de) 2007-03-01
DE502006008291D1 (de) 2010-12-23
ATE487390T1 (de) 2010-11-15

Similar Documents

Publication Publication Date Title
WO2005102301A3 (en) Hydroxymethylbutyrate compositions and uses thereof
WO2006103037A3 (de) ZUSAMMENSETZUNG ENTHALTEND β-DEFENSIN 2
WO2005023866A3 (en) Peptides that inhibit complement activation
BR9906438A (pt) Composição de reforço nutricional apropriada para o tratamento de úlceras de pressão
EP1614675A3 (en) Amino acids with affinity for the alpha-2-delta protein
DK1455603T3 (da) Stimulering af in vivo produktion af proteiner med en formulering, der omfatter leucin
EP2065040A3 (en) Sphingolipids against pathological processes in lipid rafts
WO2005023185A3 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
WO2006068729A3 (en) Methods and compositions for enhancing iron absorption
MXPA05014082A (es) Acidos biariloximetilarenocarboxilicos.
HRP20041132A2 (en) 7-aryl-3, 9-diazabicyclo (3.3.1) non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
UA86937C2 (ru) Композиция, которая содержит лактат и калий, и ее применение
WO2006099941A8 (de) Aminocarbonyl substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
TW200621765A (en) Substituted phenylaminothiazoles and their use
MY141972A (en) Biaryloxymethylarenecarboxylic acids
EP2241196A3 (en) Nutritional supplement comprising oligosaccharides and cysteine for treating hiv
PL1916913T3 (pl) Preparat białkowy do leczenia uwarunkowanego fizjologicznie klinicznie nie zwracającego uwagi, zwiększonego zapotrzebowania na białko
DE50207740D1 (de) Verwendung von phosphatidylserin zur behandlung des aufmerksamkeits-defizit-syndroms (adhs)
NZ541231A (en) A method of treatment or prophylaxis of symptoms of herpes viral infection
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
WO2003086335A8 (en) Hair care composition for restoring the elasticity of hair
HRP20080255A2 (hr) Upotreba cikletanina i drugih furopiridina za liječenje pretežno sistolsne hipertenzije, izolirane sistolne hipertenzije, povišenog pulsnog tlaka i opće hipertenzije
WO2007125142A8 (es) Péptidos lineales antimicrobianos
EP1068868A3 (en) Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.